255 related articles for article (PubMed ID: 33209669)
1. Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA).
Xing Q; Liu S; Jiang S; Li T; Wang Z; Wang Y
Transl Androl Urol; 2020 Oct; 9(5):2054-2070. PubMed ID: 33209669
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
Chen L; Lin J; Wen Y; Chen Y; Chen CB
Front Oncol; 2023; 13():1291720. PubMed ID: 38023241
[TBL] [Abstract][Full Text] [Related]
3. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
Qiu H; Hu X; He C; Yu B; Li Y; Li J
Front Genet; 2020; 11():12. PubMed ID: 32117435
[TBL] [Abstract][Full Text] [Related]
5. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
6. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
7. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
Front Oncol; 2021; 11():766072. PubMed ID: 34868990
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
Wang S; Cheng L; Jing F; Li G
BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
[TBL] [Abstract][Full Text] [Related]
9. Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.
Deng Y; Hong X; Yu C; Li H; Wang Q; Zhang Y; Wang T; Wang X
Oncol Lett; 2021 May; 21(5):344. PubMed ID: 33747201
[TBL] [Abstract][Full Text] [Related]
10. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
11. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Front Oncol; 2020; 10():1588. PubMed ID: 33014809
[TBL] [Abstract][Full Text] [Related]
12. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
Front Oncol; 2021; 11():686044. PubMed ID: 34422642
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.
Qin R; Li C; Wang X; Zhong Z; Sun C
Cancer Cell Int; 2021 Jul; 21(1):378. PubMed ID: 34266418
[TBL] [Abstract][Full Text] [Related]
14. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
15. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
17. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an immune-related gene prognostic model for head and neck tumors.
Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
[TBL] [Abstract][Full Text] [Related]
19. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
20. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
